FIELD: medicine.
SUBSTANCE: invention relates to a method for determination of a circulating conjugated anti-drug antibody comprising a therapeutic polypeptide and an endogenous anti-drug antibody formed in vivo to establish a correlation between the altered pharmacokinetics and a loss or decrease in efficacy including the steps of serum or cerebrospinal fluid exclusion chromatography from a mammal to which the drug is administered at least once, to determine the immunocomplex mass/size, and at least one heterogeneous immunoassay to detect a conjugated anti-drug antibody. Where the therapeutic polypeptide is a synthetic or non-natural therapeutic polypeptide.
EFFECT: invention provides a correlation with altered pharmacokinetics, loss or decrease in efficacy, neutralisation of natural analogues, as well as with general immune responses and hypersensitivity reactions including serum reaction, type III hypersensitivity, immune complex mediated disease.
7 cl, 3 ex, 6 dwg, 15 tbl
Title |
Year |
Author |
Number |
METHOD FOR DETECTING ANTIBODIES TO DRUGS WITH RESPECT TO HUMAN OR HUMANISED MEDICINAL ANTIBODIES WITH SUPPRESSED EFFECTOR FUNCTION |
2015 |
- Umana Pablo
- Vessels Uve
- Shtubenraukh Kaj-Gunnar
|
RU2719642C2 |
METHOD FOR DETERMINING ANTI-DRUG ANTIBODY ISOTYPE |
2011 |
- Van Shuj Lun
- Ormund Linda
- Khauenshtajn Skott
- Singkh Sharat
|
RU2574976C2 |
METHODS, DEVICES, KITS, AND COMPOSITIONS FOR DETECTION OF TAPEWORMS |
2019 |
- Geng, Jinming
- Elsemore, David, Allen
|
RU2782463C1 |
METHOD FOR MULTISPECIFIC BINDING AGENT DETECTION |
2013 |
- Shtubenraukh Kaj-Gunnar
- Tsadak Markus
|
RU2636822C2 |
METHOD OF DETECTING ANTI-TNF PREPARATIONS AND AUTOANTIBODIES |
2010 |
- Singkh Sharat
- Van Shuj Lun
- Ormund Linda
|
RU2571489C2 |
METHOD FOR SELECTION AND PRODUCTION OF SELECTIVE AND MULTISPECIFIC THERAPEUTIC MOLECULES WITH SPECIFIED PROPERTIES, INCLUDING, AT LEAST TWO, DIFFERENT TARGET GROUPS, AND THEIR APPLICATIONS |
2013 |
- Khajndl Diter
- Khyulsmann Peter Mikhel
- Kalutsa Brigitt
- Kopetski Erkhard
- Niderfellner Gerkhard
- Tifentaler Georg
|
RU2644263C2 |
DEVICES AND METHOD TO PRODUCE HIGHLY CLEANED NEUROTOXINS |
2010 |
- Pfajl' Mikhaehl'
- Fridrikh Jozef
- Tehjlor Kharol'D V.
- Ajzele Karl-Khajnts
- Brjunn Kornelija
|
RU2571212C2 |
COMPOSITIONS AND APPLICATION METHODS FOR DETECTING HE4a |
2011 |
- Khellstrom Inzhgerd
- Khellstrom Karl-Erik
- Rejkraft Dzhon
- Fermer Kristian
- Rojzher Eva
|
RU2650778C2 |
SOLID PHASE ENZYME-IMMUNOASSAY (ELIZA) FOR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) |
2007 |
- Mehn Juj-Tszjuj G
- Khun Kjuj Kh
- Gut'Erres Dzhonni
|
RU2517301C2 |
HIGH-SENSITIVITY IMMUNOASSAYS AND KITS FOR DETECTING PEPTIDES AND PROTEINS OF INTEREST |
2007 |
- Sarasa Barrio Kh Manuehl'
|
RU2461837C2 |